表紙:関節炎向けモノクローナル抗体の世界市場(2022年)
市場調査レポート
商品コード
1062960

関節炎向けモノクローナル抗体の世界市場(2022年)

Arthritis Monoclonal Antibodies Global Market Report 2022

出版日: 受注後作成 | 発行: The Business Research Company | ページ情報: 英文 400 Pages | 納期: 2~10営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.18円
関節炎向けモノクローナル抗体の世界市場(2022年)
出版日: 受注後作成
発行: The Business Research Company
ページ情報: 英文 400 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

当レポートでは、世界の関節炎向けモノクローナル抗体市場について調査分析し、市場の特徴、市場の動向と戦略、市場分析、競合情勢など、体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 関節炎向けモノクローナル抗体市場の特徴

第3章 関節炎向けモノクローナル抗体の市場動向と戦略

第4章 関節炎向けモノクローナル抗体に対するCOVID-19の影響

第5章 関節炎向けモノクローナル抗体の市場規模と成長

  • 世界の関節炎向けモノクローナル抗体市場実績、10億米ドル(2016年~2021年)
    • 市場促進要因
    • 市場抑制要因
  • 世界の関節炎向けモノクローナル抗体市場予測、10億米ドル(2021年~2026年)(2031年)
    • 市場促進要因
    • 市場抑制要因

第6章 関節炎向けモノクローナル抗体市場のセグメンテーション

  • 世界の関節炎向けモノクローナル抗体市場、実績および予測、10億米ドル(2016年~2021年)(2021年~2026年)(2031年):薬剤別
  • レミケード
  • ヒュミラ
  • エンブレル
  • リツキサン
  • オレンシア
  • アクテムラ
  • シンポニー
  • セルトリズマブ
  • レムシマ
  • 世界の関節炎向けモノクローナル抗体市場、実績および予測、10億米ドル(2016年~2021年)(2021年~2026年)(2031年):アプリケーション別
  • 関節リウマチ
  • 変形性関節症
  • 乾癬性関節炎
  • 強直性脊椎炎
  • 線維筋痛症
  • その他
  • 世界の関節炎向けモノクローナル抗体市場、実績および予測、10億米ドル(2016年~2021年)(2021年~2026年)(2031年):最終用途別
  • 病院
  • 研究
  • その他

第7章 関節炎向けモノクローナル抗体市場の地域および国の分析

  • 世界の関節炎向けモノクローナル抗体市場、実績および予測、10億米ドル(2016年~2021年)(2021年~2026年)(2031年):地域別
  • 世界の関節炎向けモノクローナル抗体市場、実績および予測、10億米ドル(2016年~2021年)(2021年~2026年)(2031年):国別

第8章 アジア太平洋の関節炎向けモノクローナル抗体市場

第9章 中国の関節炎向けモノクローナル抗体市場

第10章 インドの関節炎向けモノクローナル抗体市場

第11章 日本の関節炎向けモノクローナル抗体市場

第12章 オーストラリアの関節炎向けモノクローナル抗体市場

第13章 インドネシアの関節炎向けモノクローナル抗体市場

第14章 韓国の関節炎向けモノクローナル抗体市場

第15章 西欧の関節炎向けモノクローナル抗体市場

第16章 英国の関節炎向けモノクローナル抗体市場

第17章 ドイツの関節炎向けモノクローナル抗体市場

第18章 フランスの関節炎向けモノクローナル抗体市場

第19章 東欧の関節炎向けモノクローナル抗体市場

第20章 ロシアの関節炎向けモノクローナル抗体市場

第21章 北米の関節炎向けモノクローナル抗体市場

第22章 米国の関節炎向けモノクローナル抗体市場

第23章 南米の関節炎向けモノクローナル抗体市場

第24章 ブラジルの関節炎向けモノクローナル抗体市場

第25章 中東の関節炎向けモノクローナル抗体市場

第26章 アフリカの関節炎向けモノクローナル抗体市場

第27章 関節炎向けモノクローナル抗体市場の競合情勢と企業プロファイル

  • 関節炎向けモノクローナル抗体市場の競合情勢
  • 関節炎向けモノクローナル抗体市場の企業プロファイル
    • Johnson & Johnson
    • Roche
    • Novartis
    • Pfizer Inc
    • AbbVie Inc.

第28章 関節炎向けモノクローナル抗体パイプライン分析

第29章 関節炎向けモノクローナル抗体市場における主要な合併と買収

第30章 関節炎向けモノクローナル抗体市場の将来展望と潜在的分析

第31章 付録

目次
Product Code: h1182

“Arthritis Monoclonal Antibodies Global Market Report 2022” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global arthritis monoclonal antibodies (mab's) market.

This report focuses on arthritis monoclonal antibodies (mab's) market which is experiencing strong growth. The report gives a guide to the arthritis monoclonal antibodies (mab's) market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the arthritis monoclonal antibodies (mab's)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Arthritis Monoclonal Antibodies (mab's) market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider arthritis monoclonal antibodies (mab's) market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The arthritis monoclonal antibodies (mab's) market section of the report gives context. It compares the arthritis monoclonal antibodies (mab's) market with other segments of the arthritis monoclonal antibodies (mab's) market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, arthritis monoclonal antibodies (mab's) indicators comparison.

Scope

Markets Covered:

1) By Drug: Remicade; Humira; Enbrel; Rituxan; Orencia; Actemra; Simponi; Cimzia; Remsima

2) By Application: Rheumatoid Arthritis; Osteoarthritis; Psoriatic Arthritis; Ankylosing Spondylitis; Fibromyalgia; Others

3) By End-Use: Hopitals; Research Institutes; Others

Companies Mentioned: Johnson & Johnson; Roche; Novartis; Pfizer Inc.; AbbVie Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Arthritis Monoclonal Antibodies Market Characteristics

3. Arthritis Monoclonal Antibodies Market Trends And Strategies

4. Impact Of COVID-19 On Arthritis Monoclonal Antibodies

5. Arthritis Monoclonal Antibodies Market Size And Growth

  • 5.1. Global Arthritis Monoclonal Antibodies Historic Market, 2016-2021, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Arthritis Monoclonal Antibodies Forecast Market, 2021-2026F, 2031F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Arthritis Monoclonal Antibodies Market Segmentation

  • 6.1. Global Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Remicade
  • Humira
  • Enbrel
  • Rituxan
  • Orencia
  • Actemra
  • Simponi
  • Cimzia
  • Remsima
  • 6.2. Global Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Rheumatoid Arthritis
  • Osteoarthritis
  • Psoriatic Arthritis
  • Ankylosing Spondylitis
  • Fibromyalgia
  • Others
  • 6.3. Global Arthritis Monoclonal Antibodies Market, Segmentation By End-use, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • Hopitals
  • Research Institutes
  • Others

7. Arthritis Monoclonal Antibodies Market Regional And Country Analysis

  • 7.1. Global Arthritis Monoclonal Antibodies Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 7.2. Global Arthritis Monoclonal Antibodies Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific Arthritis Monoclonal Antibodies Market

  • 8.1. Asia-Pacific Arthritis Monoclonal Antibodies Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 8.3. Asia-Pacific Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China Arthritis Monoclonal Antibodies Market

  • 9.1. China Arthritis Monoclonal Antibodies Market Overview
  • 9.2. China Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion
  • 9.3. China Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India Arthritis Monoclonal Antibodies Market

  • 10.1. India Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 10.2. India Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan Arthritis Monoclonal Antibodies Market

  • 11.1. Japan Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 11.2. Japan Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia Arthritis Monoclonal Antibodies Market

  • 12.1. Australia Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 12.2. Australia Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia Arthritis Monoclonal Antibodies Market

  • 13.1. Indonesia Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 13.2. Indonesia Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea Arthritis Monoclonal Antibodies Market

  • 14.1. South Korea Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 14.2. South Korea Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe Arthritis Monoclonal Antibodies Market

  • 15.1. Western Europe Arthritis Monoclonal Antibodies Market Overview
  • 15.2. Western Europe Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 15.3. Western Europe Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK Arthritis Monoclonal Antibodies Market

  • 16.1. UK Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 16.2. UK Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany Arthritis Monoclonal Antibodies Market

  • 17.1. Germany Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 17.2. Germany Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France Arthritis Monoclonal Antibodies Market

  • 18.4. France Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 18.5. France Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe Arthritis Monoclonal Antibodies Market

  • 19.1. Eastern Europe Arthritis Monoclonal Antibodies Market Overview
  • 19.2. Eastern Europe Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 19.3. Eastern Europe Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia Arthritis Monoclonal Antibodies Market

  • 20.1. Russia Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 20.2. Russia Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America Arthritis Monoclonal Antibodies Market

  • 21.1. North America Arthritis Monoclonal Antibodies Market Overview
  • 21.2. North America Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 21.3. North America Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA Arthritis Monoclonal Antibodies Market

  • 22.1. USA Arthritis Monoclonal Antibodies Market Overview
  • 22.2. USA Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 22.3. USA Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America Arthritis Monoclonal Antibodies Market

  • 23.1. South America Arthritis Monoclonal Antibodies Market Overview
  • 23.2. South America Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 23.3. South America Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil Arthritis Monoclonal Antibodies Market

  • 24.1. Brazil Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 24.2. Brazil Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East Arthritis Monoclonal Antibodies Market

  • 25.1. Middle East Arthritis Monoclonal Antibodies Market Overview
  • 25.2. Middle East Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 25.3. Middle East Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa Arthritis Monoclonal Antibodies Market

  • 26.1. Africa Arthritis Monoclonal Antibodies Market Overview
  • 26.2. Africa Arthritis Monoclonal Antibodies Market, Segmentation By Drug, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
  • 26.3. Africa Arthritis Monoclonal Antibodies Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. Arthritis Monoclonal Antibodies Market Competitive Landscape And Company Profiles

  • 27.1. Arthritis Monoclonal Antibodies Market Competitive Landscape
  • 27.2. Arthritis Monoclonal Antibodies Market Company Profiles
    • 27.2.1. Johnson & Johnson
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Roche
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Novartis
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Pfizer Inc
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. AbbVie Inc.
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Arthritis Monoclonal Antibodies Pipeline Analysis

29. Key Mergers And Acquisitions In The Arthritis Monoclonal Antibodies Market

30. Arthritis Monoclonal Antibodies Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer